Viveve Medical Inc. (NASDAQ:VIVE) went down by -7.10% from its latest closing price compared to the recent 1-year high of $20.90. The company’s stock price has collected -7.91% of loss in the last five trading sessions. Press Release reported on 12/17/20 that Viveve Regains Compliance with NASDAQ Continued Listing Rules
Is It Worth Investing in Viveve Medical Inc. (NASDAQ :VIVE) Right Now?
Plus, the 36-month beta value for VIVE is at 0.53. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Viveve Medical Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $22.00. VIVE currently public float of 2.17M and currently shorts hold a 4.68% ratio of that float. Today, the average trading volume of VIVE was 152.38K shares.
VIVE’s Market Performance
VIVE stocks went down by -7.91% for the week, with a monthly drop of -14.49% and a quarterly performance of -22.41%, while its annual performance rate touched -54.36%. The volatility ratio for the week stands at 6.80% while the volatility levels for the past 30 days are set at 6.54% for Viveve Medical Inc.. The simple moving average for the period of the last 20 days is -8.94% for VIVE stocks with a simple moving average of -26.14% for the last 200 days.
Analysts’ Opinion of VIVE
Many brokerage firms have already submitted their reports for VIVE stocks, with Stifel repeating the rating for VIVE by listing it as a “Hold.” The predicted price for VIVE in the upcoming period, according to Stifel is $1 based on the research report published on July 23rd of the previous year 2019.
VIVE Trading at -13.63% from the 50-Day Moving Average
After a stumble in the market that brought VIVE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.95% of loss for the given period.
Volatility was left at 6.54%, however, over the last 30 days, the volatility rate increased by 6.80%, as shares sank -16.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.13% lower at present.
During the last 5 trading sessions, VIVE fell by -7.91%, which changed the moving average for the period of 200-days by -41.38% in comparison to the 20-day moving average, which settled at $4.56. In addition, Viveve Medical Inc. saw -10.85% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VIVE
Current profitability levels for the company are sitting at:
- -455.87 for the present operating margin
- +15.47 for the gross margin
The net margin for Viveve Medical Inc. stands at -647.57. The total capital return value is set at -106.27, while invested capital returns managed to touch -151.67. Equity return is now at value -279.00, with -159.40 for asset returns.
Based on Viveve Medical Inc. (VIVE), the company’s capital structure generated 26.53 points at debt to equity in total, while total debt to capital is 20.97. Total debt to assets is 16.25, with long-term debt to equity ratio resting at 24.91. Finally, the long-term debt to capital ratio is 19.69.
When we switch over and look at the enterprise to sales, we see a ratio of -1.12, with the company’s debt to enterprise value settled at -0.60. The receivables turnover for the company is 1.80 and the total asset turnover is 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.52.